Tags: metadoxine | adhd | drug | trial

New ADHD Treatment Shows Promise in Trial

Monday, 06 October 2014 07:56 AM

Alcobra Ltd said its drug to treat attention deficit disorder met the main goals of a late-stage trial, reducing the symptoms of the condition better than a sugar pill.

The study results were derived after the company excluded data from four patients who showed an extreme response to the placebo, Alcobra said in a statement.

The company said the study scored the drug, Metadoxine, on the same scale used in studies that evaluated other attention deficit hyperactivity disorder, or ADHD, drugs.

© 2019 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Alcobra Ltd said its drug to treat attention deficit disorder met the main goals of a late-stage trial, reducing the symptoms of the condition better than a sugar pill.The study results were derived after the company excluded data from four patients who showed an extreme...
metadoxine, adhd, drug, trial
81
2014-56-06
Monday, 06 October 2014 07:56 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved